CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title | Date of Registration | State |
---|---|---|
1E10 anti-idiotype vaccine, metastatic colon, phase II. | 2010-12-03 | Registered |
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II | 2010-12-27 | Registered |
1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma | 01/09/2016 | Registered outdated |
188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I. | 2010-12-27 | Registered |
14F7 MAb marked with Tc99 Phase II in breast tumors. | 2010-12-29 | Registered |
14F7 in chronic B-cell lymphoproliferative syndrome | 07/03/2018 | Registered |